Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


11.02.2019

2 Am J Dermatopathol
1 Am J Ophthalmol
3 Ann Surg Oncol
1 Anticancer Res
1 Br J Dermatol
1 Int J Cancer
5 J Am Acad Dermatol
1 J Biol Chem
2 J Cell Physiol
1 J Invest Dermatol
2 J Surg Oncol
4 Melanoma Res
1 Oncogene
4 PLoS One
3 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. CHAN C, Magro CM, Pham AK, LeBlanc RE, et al
    Spontaneous Hair Repigmentation in an 80-Year-Old Man: A Case of Melanoma-Associated Hair Repigmentation and Review of the Literature.
    Am J Dermatopathol. 2019 Jan 29. doi: 10.1097/DAD.0000000000001353.
    PubMed     Text format     Abstract available

  2. LAMBERTINI M, Baraldi C, Patrizi A, Fanti PA, et al
    Proliferative Melanocytic Nodule on Small Congenital Nevus During Treatment With Etanercept.
    Am J Dermatopathol. 2017 Oct 9. doi: 10.1097/DAD.0000000000001024.
    PubMed     Text format    


    Am J Ophthalmol

  3. MATHIS T, Rosier L, Meniai F, Baillif S, et al
    The Lens Opacities Classification System III grading in irradiated uveal melanomas to characterize proton induced cataracts.
    Am J Ophthalmol. 2019 Feb 2. pii: S0002-9394(19)30046.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  4. CHAKERA AH, Thompson JF
    ASO Author Reflections: Subungual Melanomas of the Hand Present Diagnostic and Therapeutic Challenges.
    Ann Surg Oncol. 2019 Feb 4. pii: 10.1245/s10434-019-07196.
    PubMed     Text format    

  5. EL SHAROUNI MA, Witkamp AJ, Sigurdsson V, van Diest PJ, et al
    Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma.
    Ann Surg Oncol. 2019 Feb 4. pii: 10.1245/s10434-019-07204.
    PubMed     Text format     Abstract available

  6. KING BBT, Chapman BC, Gleisner A, Stewart C, et al
    Postbiopsy Pigmentation is Prognostic in Head and Neck Melanoma.
    Ann Surg Oncol. 2019 Jan 31. pii: 10.1245/s10434-019-07185.
    PubMed     Text format     Abstract available


    Anticancer Res

  7. MANTSO T, Anestopoulos I, Lamprianidou E, Kotsianidis I, et al
    Isothiocyanate-induced Cell Cycle Arrest in a Novel In Vitro Exposure Protocol of Human Malignant Melanoma (A375) Cells.
    Anticancer Res. 2019;39:591-596.
    PubMed     Text format     Abstract available


    Br J Dermatol

  8. ZOUTENDIJK J, Tio D, Koljenovic S, van den Bos RR, et al
    Nine percent of biopsy proven lentigo maligna are reclassified as lentigo maligna melanoma after surgery.
    Br J Dermatol. 2019 Feb 4. doi: 10.1111/bjd.17714.
    PubMed     Text format     Abstract available


    Int J Cancer

  9. DAI W, Liu H, Xu X, Jie G, et al
    Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival.
    Int J Cancer. 2019 Feb 8. doi: 10.1002/ijc.32194.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  10. DARMAWAN CC, Jo G, Montenegro SE, Kwak Y, et al
    Early Detection of Acral Melanoma: A Review of Clinical, Dermoscopic, Histopathologic, and Molecular Characteristics.
    J Am Acad Dermatol. 2019 Feb 4. pii: S0190-9622(19)30192.
    PubMed     Text format     Abstract available

  11. OH CC, Jin A, Yuan JM, Koh WP, et al
    Coffee, tea, caffeine, and risk of non-melanoma skin cancer in a Chinese population: The Singapore Chinese Health Study.
    J Am Acad Dermatol. 2019 Feb 4. pii: S0190-9622(19)30195.
    PubMed     Text format     Abstract available

  12. TAYLOR NJ, Mitra N, Qian L, Avril MF, et al
    Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.
    J Am Acad Dermatol. 2019 Feb 4. pii: S0190-9622(19)30190.
    PubMed     Text format     Abstract available

  13. WEI EX, Li X, Nan H
    Extremity nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma.
    J Am Acad Dermatol. 2019 Jan 31. pii: S0190-9622(18)32655.
    PubMed     Text format     Abstract available

  14. KO D, Lipner SR
    Comment on: "The first 30 years of the American Academy of Dermatology skin cancer screening program: 1985-2014".
    J Am Acad Dermatol. 2019;80:e23.
    PubMed     Text format    


    J Biol Chem

  15. DENG W, Fernandez A, McLaughlin SL, Klinke DJ 2nd, et al
    WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial - mesenchymal transition.
    J Biol Chem. 2019 Feb 5. pii: RA118.006122. doi: 10.1074/jbc.RA118.006122.
    PubMed     Text format     Abstract available


    J Cell Physiol

  16. PAYANDEH Z, Yarahmadi M, Nariman-Saleh-Fam Z, Tarhriz V, et al
    Immune therapy of melanoma: Overview of therapeutic vaccines.
    J Cell Physiol. 2019 Jan 31. doi: 10.1002/jcp.28181.
    PubMed     Text format     Abstract available

  17. LI J, Chen J, Wang S, Li P, et al
    Blockage of transferred exosome-shuttled miR-494 inhibits melanoma growth and metastasis.
    J Cell Physiol. 2019 Feb 5. doi: 10.1002/jcp.28234.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  18. ZHANG X, Peng Y, Li C, Li Q, et al
    Genomic heterogeneity and branched evolution of early-stage primary acral melanoma revealed by multi-regional microdissection sequencing.
    J Invest Dermatol. 2019 Jan 30. pii: S0022-202X(19)30045.
    PubMed     Text format     Abstract available


    J Surg Oncol

  19. PEREZ MC, Sun J, Farley C, Han D, et al
    Management of intussusception in patients with melanoma.
    J Surg Oncol. 2019 Feb 7. doi: 10.1002/jso.25393.
    PubMed     Text format     Abstract available

  20. READ T, Lonne M, Sparks DS, David M, et al
    A systematic review and meta-analysis of locoregional treatments for in-transit melanoma.
    J Surg Oncol. 2019 Feb 7. doi: 10.1002/jso.25400.
    PubMed     Text format     Abstract available


    Melanoma Res

  21. BOSELLO F, Al-Jamal RT, Cohen VML
    Very late recurrence of iris melanoma: 45 years after treatment.
    Melanoma Res. 2019 Feb 5. doi: 10.1097/CMR.0000000000000581.
    PubMed     Text format     Abstract available

  22. XU W, Moor RJ, Walpole ET, Atkinson VG, et al
    Pregnancy with successful foetal and maternal outcome in a melanoma patient treated with nivolumab in the first trimester: case report and review of the literature.
    Melanoma Res. 2019 Feb 5. doi: 10.1097/CMR.0000000000000586.
    PubMed     Text format     Abstract available

  23. FERNANDEZ-SARTORIO C, Boada A, Chavez-Bourgeois MM, Ruiz Ares GJ, et al
    Aged-looking skin and encorafenib: an adverse event of BRAF inhibitors.
    Melanoma Res. 2018;28:160-162.
    PubMed     Text format    

  24. MUTO Y, Ng W, Namikawa K, Takahashi A, et al
    Success of rechallenging dabrafenib and trametinib combination therapy after trametinib-induced rhabdomyolysis: a case report.
    Melanoma Res. 2018;28:151-154.
    PubMed     Text format     Abstract available


    Oncogene

  25. PEROTTI V, Baldassari P, Molla A, Nicolini G, et al
    An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells.
    Oncogene. 2019 Feb 1. pii: 10.1038/s41388-019-0729.
    PubMed     Text format     Abstract available


    PLoS One

  26. PO JW, Ma Y, Balakrishna B, Brungs D, et al
    Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status.
    PLoS One. 2019;14:e0211866.
    PubMed     Text format     Abstract available

  27. SUROWKA G, Ogorzalek M
    Resolution invariant wavelet features of melanoma studied by SVM classifiers.
    PLoS One. 2019;14:e0211318.
    PubMed     Text format     Abstract available

  28. VAN LAAR R, Lincoln M, Fereday S
    Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma.
    PLoS One. 2019;14:e0211504.
    PubMed     Text format     Abstract available

  29. SHAHRIYARI L, Abdel-Rahman M, Cebulla C
    BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
    PLoS One. 2019;14:e0211507.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  30. CHEUNG LS, Fu J, Kumar P, Kumar A, et al
    Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma.
    Proc Natl Acad Sci U S A. 2019 Feb 4. pii: 1815087116.
    PubMed     Text format     Abstract available

  31. DU X, de Almeida P, Manieri N, de Almeida Nagata D, et al
    CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1.
    Proc Natl Acad Sci U S A. 2018;115:E11731-E11740.
    PubMed     Text format     Abstract available

  32. SANG B, Zhang YY, Guo ST, Kong LF, et al
    Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence.
    Proc Natl Acad Sci U S A. 2018;115:E11661-E11670.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: